cnty-101
·Code: CNTY-101
cnty-101: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Century Therapeutics, Inc. (IPSC) | Phase 1 |
Clinical Trials (1)
The ELiPSE-1 Study: A Phase 1, Multicenter, Open-Label Study of CNTY-101 in Subjects With Relapsed or Refractory CD19-Positive B-Cell Malignancies
Frequently asked questions
Who is developing cnty-101?
cnty-101 is being developed by Century Therapeutics, Inc..
How many clinical trials involve cnty-101?
BioSniper tracks 1 clinical trial involving cnty-101.
Get deeper analysis on cnty-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis